SCHEMBL6740779

SCHEMBL6740779

[CH2]c1c(N)cccc1[N+](=O)[O-]

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 6/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
PDE7A Q13946 1/20 0.50
GPR35 Q9HC97 2/20 0.48
TSHR P16473 4/20 0.44
ALDH1A1 P00352 2/20 0.44
MEN1 O00255 2/20 0.44
MAPT P10636 2/20 0.44
KMT2A Q03164 2/20 0.44
POLB P06746 1/20 0.44
CYP3A4 P08684 1/20 0.44
ALOX15 P16050 1/20 0.44
GAA P10253 2/20 0.43
ERN1 O75460 1/20 0.43
S100A4 P26447 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MGAM O43451 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL83317 0.84 TDP1 (0.61) TDP1SMN1; SMN2GPR35TSHRALDH1A1
SCHEMBL24548 0.78 TDP1 (0.60) TDP1SMN1; SMN2PDE7AGPR35TSHR
SCHEMBL29448254 0.78 TDP1 (0.60) TDP1SMN1; SMN2PDE7AGPR35TSHR
SCHEMBL10381945 0.78 PDE7A (0.62) TDP1SMN1; SMN2PDE7AGPR35TSHR
2-Nitroaniline SCHEMBL6000 0.78 PDE7A (0.62) TDP1SMN1; SMN2PDE7AGPR35TSHR
2-Nitroaniline SCHEMBL29396517 0.78 PDE7A (0.62) TDP1SMN1; SMN2PDE7AGPR35TSHR
SCHEMBL1913575 0.78 ALDH1A1 (0.52) TDP1SMN1; SMN2PDE7AGPR35TSHR
SCHEMBL32674585 0.78 ALDH1A1 (0.52) TDP1SMN1; SMN2PDE7AGPR35TSHR
SCHEMBL17934 0.77 TSHR (0.59) TDP1SMN1; SMN2PDE7AGPR35TSHR
SCHEMBL9141067 0.76 ERN1 (0.49) TDP1SMN1; SMN2PDE7AGPR35TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102918044-A Fused quinazoline derivatives and uses thereof SHENZHEN SALUBRIS PHARM CO LTD 2013-02-06 CN disclosed
US-6689771-B2 TREATMENT OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, PERIODONTITIS, GINGIVITIS, CORNEAL ULCERATION, SOLID TUMOR GROWTH BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-02-10 US disclosed
US-6376665-B1 ANTIARTHRITIC AGENTS, ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-04-23 US disclosed
EP-1165500-A1 AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES,TNF-ALPHA,AND AGGRECANASE Du Pont Pharmaceuticals Company (US) 2002-01-02 EP disclosed
WO-2000059874-A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE DU PONT PHARMACEUTICALS COMPANY (US) 2000-10-12 WO disclosed